Emerging Company Profile

SciNeuro reunites GSK R&D vets to bring CNS therapies to China 

Emerging Company Profile: SciNeuro to build neurodegeneration, neuropsychiatric pipeline via partnering, in-house R&D

Founder and CEO Min Li discusses the company’s partnering and R&D strategy.

Led by GSK neuro R&D alumni